Sr One Capital Management »

Oruka Therapeutics shares owned by Sr One Capital Management

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Sr One Capital Management from 13F filings

Historical chart of Sr One Capital Management investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Sr One Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.3M 430k 19.23
2025-06-30 $4.8M 430k 11.21
2025-03-31 $4.4M 430k 10.26
2024-12-31 $8.3M 430k 19.39
2024-09-30 $9.2M 375k 24.51

More positions owned by Sr One Capital Management

Arcellx Common Stock (ACLX)
CRISPR Therapeutics Common Shares (CRSP)
Zenas BioPharma Common Stock (ZBIO)
Mineralys Therapeutics Common Stock (MLYS)
ORIC Pharmaceuticals Common Stock (ORIC)
Design Therapeutics Common Stock (DSGN)
ARS Pharmaceuticals Common Stock (SPRY)
Oruka Therapeutics Common Stock (ORKA)
Alumis Common Stock (ALMS)
Nkarta Common Stock (NKTX)
Oculis Holding Ordinary Shares (OCS)
enGene Holdings Common Shares (ENGN)

View all positions for Sr One Capital Management

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
Viking Global Investors
Deep Track Capital
BlackRock
Rtw Investments
Vanguard Group
Commodore Capital
Braidwell
venBio Select Advisor
Perceptive Advisors
Franklin Resources
Point72 Asset Management
Polar Capital Holdings

View all funds holding Oruka Therapeutics